3Houck KA,Leung DW,Rowland AM,et al.Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms[J].J Biol Chem,1992,267(36):26031-26037.
4Thiagalingam S,Lengauer C,Leach FS,et al.Evaluation ofcandidate tumour suppressor genes on chromosome 18 in colorectal cancers[J].Nat Genet,1996,13(3):343-346.
5Ma DM,Xu YP,Zhu L.Expression of vascular endothelial growth factor C correlates with a poor prognosis based on analysis of prognostic factors in patients with cervical cardnornas[J].J Obstet Gynaecol Res,2011,37(11):1519-1524.
6Donnem T,A1-Saad S,A1-Shibli K,et al.Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer[J].Clin Cancer Res,2007,13(22 Pt 1):6649-6657.
7Hu WG,Li JW,Feng B,et al.Vascular endothelial growth factors C and D represent novel prognostic markers in eolorectal carcinoma using quantitative image analysis[J].Eur Surg Res,2007,39(4):229-238.
8Alhopuro P,Alazzouzi H,Sammalkorpi H,et al.SMAD4 levels and response to 5-fluorouracil in colorectal cancer[J].Clin Cancer Res,2005,11(17):6311-6316.
9Mesker WE,Liefers GJ,Junggeburt JM,et al.Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-n colon cancer patients[J].Cell Onto1,2009,31(3):169-178.
10Hiwatashi K,Ueno S,Sakoda M,et al.Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular careinoma[J].Ann Surg Oneol,2009,16(11):3176-3182.
